Local media: UC, UC Health to examine potential COVID-19 treatment

In the absence of an approved treatment for COVID-19, in March the FDA began allowing researchers to request emergency authorization for the use of convalescent plasma which shows potential as a treatment for the disease.

Researchers at the UC College of Medicine are among those who joined the Mayo Clinic protocol for investigating convalescent plasma as a possible treatment for COVID-19. Convalescent plasma is obtained from people who have recovered from COVID-19 and have been free of symptoms for 28 days. This program may allow access to that plasma for hospitalized patients infected with the novel coronavirus who have severe or life-threatening COVID-19, or who may be at high risk for progression to severe or life-threatening disease.

This research garnered coverage from the Cincinnati Business Courier, Cincinnati Enquirer, WLWT, Fox19 and WVXU

Featured image at top from freestocks on Unsplash.

Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.

Related Stories

2

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.